Clinical Trial Update: A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating intravenous benapenem for efficacy and safety in patients with complicated urinary tract infection, including acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• Benapenem (benapenem)

Snippet

Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. | Conditions: Complicated Urinary Tract Infection Including Acute Pyelonephritis | Phase 2, Phase 3 | Status: COMPLETED